Kathy L. Hibbs Sells 38,551 Shares of 23andMe Holding Co. (NASDAQ:ME) Stock

23andMe Holding Co. (NASDAQ:ME) insider Kathy L. Hibbs sold 38,551 shares of the stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $0.49, for a total value of $18,889.99. Following the completion of the transaction, the insider now owns 1,252,315 shares in the company, valued at $613,634.35. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

23andMe Price Performance

ME stock traded down $0.02 during mid-day trading on Monday, reaching $0.49. The company had a trading volume of 4,795,432 shares, compared to its average volume of 6,909,976. 23andMe Holding Co. has a 52 week low of $0.35 and a 52 week high of $2.21. The company has a market capitalization of $234.99 million, a price-to-earnings ratio of -0.44 and a beta of 1.24. The stock has a 50 day simple moving average of $0.49 and a two-hundred day simple moving average of $0.70.

23andMe (NASDAQ:ME) last issued its earnings results on Wednesday, February 7th. The company reported ($0.17) earnings per share for the quarter. The firm had revenue of $44.75 million for the quarter, compared to analyst estimates of $56.30 million. 23andMe had a negative return on equity of 52.99% and a negative net margin of 210.48%.

Institutional Investors Weigh In On 23andMe

Several hedge funds have recently bought and sold shares of the company. Wittenberg Investment Management Inc. lifted its holdings in 23andMe by 63.9% during the 1st quarter. Wittenberg Investment Management Inc. now owns 2,290,945 shares of the company’s stock valued at $1,219,000 after purchasing an additional 893,552 shares during the last quarter. China Universal Asset Management Co. Ltd. boosted its holdings in shares of 23andMe by 68.3% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 60,653 shares of the company’s stock worth $32,000 after buying an additional 24,604 shares during the period. Mirador Capital Partners LP grew its stake in 23andMe by 11.2% in the 1st quarter. Mirador Capital Partners LP now owns 340,946 shares of the company’s stock valued at $181,000 after buying an additional 34,321 shares during the last quarter. BKA Wealth Consulting Inc. bought a new position in 23andMe in the 4th quarter valued at about $126,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in 23andMe by 58.0% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 61,167 shares of the company’s stock worth $56,000 after acquiring an additional 22,460 shares during the last quarter. 36.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Citigroup lowered their price objective on shares of 23andMe from $0.85 to $0.47 and set a “neutral” rating on the stock in a report on Tuesday, April 16th.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.